Voir la source de A Dirty Reality Regarding GDC-0449

There are many studies that investigated the prognostic factors for patient survival and tumor control after radiosurgery. In one study [19], the extension of the extracranial illness (p=0.001), male sex (p=0.02) and different tumor types (p=0.006) were statistically significant prognostic factors. A statistically significant correlation between tumor volume and the prescription radiation dose and final tumor [http://www.selleckchem.com/products/MS-275.html click here] control rate was not found [19]. Tendulkar et al. [44] concluded lung cancer (p=0.02) as the subtype identified as a positive predictor and prior WBRT (p=0.03) as a less favorable response to radiosurgery. The most important prognostic value was the RPA classification (p[https://en.wikipedia.org/wiki/Quinapyramine Quinapyramine] Sneed et al. [46] found a median survival rate of 14 months for patients in RPA class I and 8.2 months for patients in RPA class II. Another study [27] also reported an overall median survival after radiosurgery of 17.8 months (range 1-39 months); 17.8 months for patients in RPA class I, 10.9 months for patients in RPA class II, and 6.1 months for patients in RPA class III. Therefore, RPA classifications can be used as a valid tool for predicting prognosis in patients with brain metastases. Patients in RPA class III are typically not healthy enough to permit general anesthesia [http://www.selleckchem.com/products/GDC-0449.html GDC-0449 price] for surgery, but the great advantage of radiosurgery is that this modality can be performed using only local anesthesia. This reinforces the efficacy of radiosurgery after stereotactic cyst aspiration for inaccessible cystic lesions on a wide range of patient types [27]. CONCLUSION The aim of this review is to evaluate and assess the use of combining stereotactic drainage in cystic metastases tumors in improving the efficacy and feasibility of radiosurgery. The results of the cited studies show great potential in the non-surgical management of cystic metastases. There have been no direct, randomized clinical comparisons between radiosurgery and other surgical-radiation protocols, but it has been shown that patients with single lesions can achieve similar or better results with radiosurgery when compared to those who were treated with other protocols [22,47,48,49,50]. Stereotactic radiosurgery is a non-invasive and effective treatment tool when measured in terms of local tumor control and patient survival rates. Surgery and radiosurgery should not be considered as separate treatment techniques, but rather complementary.